NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
3.255
-0.045 (-1.39%)
Nov 21, 2024, 10:58 AM EST - Market open

NEXGEL Revenue

NEXGEL had revenue of $2.94M in the quarter ending September 30, 2024, with 140.79% growth. This brings the company's revenue in the last twelve months to $6.73M, up 90.57% year-over-year. In the year 2023, NEXGEL had annual revenue of $4.09M with 99.66% growth.

Revenue (ttm)
$6.73M
Revenue Growth
+90.57%
P/S Ratio
3.24
Revenue / Employee
$354,158
Employees
19
Market Cap
24.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.09M2.04M99.66%
Dec 31, 20222.05M497.00K32.04%
Dec 31, 20211.55M877.00K130.12%
Dec 31, 2020674.00K-43.00K-6.00%
Dec 31, 2019717.00K-1.50M-67.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neuronetics 72.71M
Bionano Genomics 33.33M
Bolt Biotherapeutics 9.78M
NeuroOne Medical Technologies 3.92M
NeurAxis 2.46M
Revenue Rankings